dailynewsnblog
University Health Network (UHN) is Canada’s leading research hospital, the world’s #2 hospital, and one of the top 20 research commercialization hospitals in North America. Home to Canada’s largest hospital-based research enterprise, it is home to 1,250 principal investigators and 5,100 research staff and trainees, with $688 million in annual research funding. UHN Commercialization has helped launch 20 financed life sciences companies, including BlueRock Therapeutics, Trillium Therapeutics, and AVROBIO. Since 2018, UHN-incubated ventures have generated more than $5 billion in economic impact through six equity exits and raised more than $1.76 billion in financing, translating world-leading research into therapies, diagnostics, and technologies that improve patient care globally.
